Blog

REDDSTAR kicks off Debating Science Issues 2015

In conjunction with Ireland’s Science Week, Debating Science Issues (DSI) the cross border biomedical, bioethical project is being launched with an upper secondary school workshop series. NUI Galway-coordinated REDDSTAR leads the assemblage of collaborators delivering the schools’ science programme now in its eighth year. Although the workshop phase of the Debating Science Issues project is…

Stem Cell Documentary Screening takes place in Galway

“Stem Cell Revolutions – a documentary screening” took place last Wednesday 12th November in Galway. You’ve heard so much about stem cells. But what do they really do? This screening allowed the audience to discover the history and ‘real science’ of stem cell research – in a documentary made in close collaboration between filmmakers and scientists. The screening was part…

REDDSTAR’s Exploitation Workshop

REDDSTAR’s Exploitation Workshop was held on 21 October in Porto. This workshop was planned as part of our ‘Description of Work’ to gain some external steering and advice at the two year mark in the project. ‘REDD6’ refers to the groups working on the six complications of diabetes explored through REDDSTAR- cardiomyopathy, foot ulceration, nephropathy,…

Cátedra em Medicina da Dor assinala Dia Nacional de Luta Contra a Dor

“Hoje celebra-se o Dia Nacional de Luta Contra a Dor mas também se dá início ao Ano Internacional contra a Dor Neuropática. Por este motivo decidimos realizar um simpósio sobre a Dor na Neuropatia Diabética”, salientou ontem José Castro Lopes, Professor responsável pela Cátedra em Medicina da Dor que resulta de uma pareceria entre a…

‘Diabetes – it’s complicated’ event attended by over 100 delegates

More than 100 delegates attended the public gathering ‘Diabetes- it’s complicated’ last evening in Aras Moyola at National University of Ireland (NUI) in Galway. Six multidisciplinary talks were delivered on a variety of topics including what makes Galway a great place for cell therapy and for advancing treatments in diabetes, diabetic eye disease, what are…

REDDSTAR journal article in Drug Discovery Today: Disease Models

REDDSTAR’s partner from University of Munich, Germany (Ludwig-Maximilians-Universität München, LMU-M) have had a journal article published in Drug Discovery Today: Disease Models. LMU-M are working in the area of diabetic nephropathy and are examining how mesenchymal stromal cells may help. This new journal article focuses on animal models of kidney inflammation for drug development. The…

REDDSTAR Mid-Project Report

The REDDSTAR Mid-Project Report has been published, and is also available here. —————————————————————————————— REDDSTAR Repair of Diabetic Damage by Stromal Cell Administration Mid-Project Report – .pdf version Description of work performed to date The central objective during the initial 18 months of REDDSTAR has been to assess the effect of MSC (mesenchymal stem cell) therapy in each of six…

NUI Galway Public Forum on Diabetes

On Tuesday, 9 September NUI Galway will host a public forum on Diabetes, delving into what research is doing to help advance treatments for complications of Type 2 diabetes. ‘Diabetes- It’s Complicated’ will take place in Room 243, Áras Moyola from 6.30-8.30pm. This free event is organised as part of the EU-funded project Repair of…

Meet Steve Elliman, Head of Research at Orbsen Therapeutics

REDDSTAR Dissemination Officer Danielle Nicholson interviewed Steve for a story which recently appeared on the EuroStemCell website.   What do you think is the most misunderstood concept or idea surrounding stem cell research? The broadest, most misunderstood concept is that all stem cell research falls under the umbrella of embryonic stem cell research. This is a…

Evaluation of preclinical studies performed within the REDDSTAR Project

Evaluation of preclinical studies performed within the REDDSTAR Project: Treatment of Diabetic Ulcers with CD362+SSC (Cyndacel-M) recommended for clinical phase 1b study. On 22nd April 2014, the REDDSTAR consortium gathered in Paris to evaluate the project’s preclinical studies on SSC treatment of diabetic complications. The central objective during the initial 18 months of the REDDSTAR…

Menu